Older Survivors of Allogeneic Hematopoietic Cell Transplantation (HCT) with Chronic Graft Vs. Host Disease (cGvHD) Demonstrate Higher Risk of Frailty As Compared with Autologous HCT Recipients: A Report from the Bone Marrow Transplant Survivor Study-2
Year: 2015
Type: article
Abstract: Approximately 10% of older (≥65y) individuals in the general population demonstrate frailty (Collard RM et al. J Am Geriatr Soc. 2012;60:1487-92). HCT recipients are at risk for accelerated aging, given the high-intensity therapeutic exposures and excessive burden of morbidity after HCT. We examined the prevalence and predictors of frailty in elderly (≥65y) HCT survivors.
Language: English
Topic: Frailty in Older Adults
Subfield: Geriatrics and Gerontology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $3,650
OpenAlex ID: W2164602527